Position in AMGN
as of Jun 30, 2026
· filed Jul 2, 2026
Position Value
$9,409,688
-$4,044,000 QoQ
Shares Held
25,985
-32.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
#569
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CX Institutional holds $115,444,232 across 15 Drug Manufacturers - General names. AMGN ranks #5 (8.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
35,493 | $42,571,372 | |
| 2 | ABBV |
AbbVie Inc.
|
78,286 | $19,699,889 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
263,596 | $15,188,401 | |
| 4 | MRK |
Merck & Co., Inc.
|
95,317 | $12,248,234 | |
| 5 | AMGN |
Amgen Inc
This page
|
25,985 | $9,409,688 | |
| 6 | JNJ |
Johnson & Johnson
|
30,364 | $7,711,545 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
58,297 | $7,365,242 | |
| 8 | PFE |
Pfizer Inc
|
27,825 | $670,026 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,409,688 | 25,985 | Shares | Sole | 2026-07-02 | |
| 2026-03-31 | $13,453,688 | 38,237 | Shares | Sole | 2026-04-06 | |
| 2025-12-31 | $12,828,915 | 39,195 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $11,558,912 | 40,960 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $10,434,077 | 37,370 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $11,535,450 | 37,026 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $10,539,239 | 40,436 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $13,002,784 | 40,355 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $3,003,894 | 9,614 | Shares | Sole | 2024-07-11 | |
| 2024-03-31 | $9,882,394 | 34,758 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $6,197,326 | 21,517 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $7,852,092 | 29,216 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $6,088,232 | 27,422 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $6,532,326 | 27,021 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $5,918,592 | 22,535 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $4,535,498 | 20,122 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $2,628,126 | 10,802 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $4,478,022 | 18,518 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $5,021,330 | 22,320 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $3,117,661 | 14,661 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $3,643,087 | 14,946 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $3,819,482 | 15,351 | Shares | Sole | 2021-04-15 | |
| 2020-12-31 | $5,973,781 | 25,982 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $7,074,289 | 27,834 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $5,762,295 | 24,431 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $4,679,008 | 23,080 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||